ReviewProbiotics and antimicrobial proteins2026
Nutritional Innovations in Functional Foods: Exploring Postbiotics for Gut and Vascular Health Enhancement.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The exploration of microbiome-targeted interventions in functional foods has accelerated, with postbiotics emerging as a compelling alternative to probiotics. Defined as non-viable microbial cells or their metabolic products, postbiotics demonstrate diverse bioactivities, including anti-inflammatory, antioxidant, and immunomodulatory effects. These attributes enable modulation of the gut-vascular axis, a critical interface influencing systemic inflammation and cardiovascular risk. Short-chain fatty acids (SCFAs), bioactive peptides, and microbial enzymes are among the most studied postbiotics with profound effects on gut integrity and vascular function. Mineral-enriched postbiotics, particularly those supplemented with zinc and selenium, offer further promise in managing metabolic syndrome and cardiovascular disorders. This review critically evaluates the molecular mechanisms through which postbiotics modulate the gut-vascular axis. We discuss the pathways associated with the improvement or eradication of gut-vascular axis-related diseases, focusing on their impact on intestinal integrity, immune regulation, and vascular function. Furthermore, we highlight the potential of postbiotics as functional food ingredients and therapeutic agents for chronic disease management, particularly in metabolic syndrome and cardiovascular disorders.
Indexed as
Identifiers
42895608What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.